These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31825821)

  • 1. A Deep Learning Framework for Predicting Response to Therapy in Cancer.
    Sakellaropoulos T; Vougas K; Narang S; Koinis F; Kotsinas A; Polyzos A; Moss TJ; Piha-Paul S; Zhou H; Kardala E; Damianidou E; Alexopoulos LG; Aifantis I; Townsend PA; Panayiotidis MI; Sfikakis P; Bartek J; Fitzgerald RC; Thanos D; Mills Shaw KR; Petty R; Tsirigos A; Gorgoulis VG
    Cell Rep; 2019 Dec; 29(11):3367-3373.e4. PubMed ID: 31825821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How much can deep learning improve prediction of the responses to drugs in cancer cell lines?
    Chen Y; Zhang L
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34529029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
    Wang Y; Yang Y; Chen S; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convolutional Neural Network Can Recognize Drug Resistance of Single Cancer Cells.
    Yanagisawa K; Toratani M; Asai A; Konno M; Niioka H; Mizushima T; Satoh T; Miyake J; Ogawa K; Vecchione A; Doki Y; Eguchi H; Ishii H
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting drug response of tumors from integrated genomic profiles by deep neural networks.
    Chiu YC; Chen HH; Zhang T; Zhang S; Gorthi A; Wang LJ; Huang Y; Chen Y
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):18. PubMed ID: 30704458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explainable drug sensitivity prediction through cancer pathway enrichment.
    Tang YC; Gottlieb A
    Sci Rep; 2021 Feb; 11(1):3128. PubMed ID: 33542382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep learning of pharmacogenomics resources: moving towards precision oncology.
    Chiu YC; Chen HH; Gorthi A; Mostavi M; Zheng S; Huang Y; Chen Y
    Brief Bioinform; 2020 Dec; 21(6):2066-2083. PubMed ID: 31813953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RefDNN: a reference drug based neural network for more accurate prediction of anticancer drug resistance.
    Choi J; Park S; Ahn J
    Sci Rep; 2020 Feb; 10(1):1861. PubMed ID: 32024872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XGraphCDS: An explainable deep learning model for predicting drug sensitivity from gene pathways and chemical structures.
    Wang Y; Yu X; Gu Y; Li W; Zhu K; Chen L; Tang Y; Liu G
    Comput Biol Med; 2024 Jan; 168():107746. PubMed ID: 38039896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale pharmacogenomic studies and drug response prediction for personalized cancer medicine.
    Feng F; Shen B; Mou X; Li Y; Li H
    J Genet Genomics; 2021 Jul; 48(7):540-551. PubMed ID: 34023295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving drug response prediction via integrating gene relationships with deep learning.
    Li P; Jiang Z; Liu T; Liu X; Qiao H; Yao X
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38600666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep learning in cancer diagnosis, prognosis and treatment selection.
    Tran KA; Kondrashova O; Bradley A; Williams ED; Pearson JV; Waddell N
    Genome Med; 2021 Sep; 13(1):152. PubMed ID: 34579788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning of mutation-gene-drug relations from the literature.
    Lee K; Kim B; Choi Y; Kim S; Shin W; Lee S; Park S; Kim S; Tan AC; Kang J
    BMC Bioinformatics; 2018 Jan; 19(1):21. PubMed ID: 29368597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision Oncology beyond Targeted Therapy: Combining Omics Data with Machine Learning Matches the Majority of Cancer Cells to Effective Therapeutics.
    Ding MQ; Chen L; Cooper GF; Young JD; Lu X
    Mol Cancer Res; 2018 Feb; 16(2):269-278. PubMed ID: 29133589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Drug Response Profile scan (CDRscan): A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature.
    Chang Y; Park H; Yang HJ; Lee S; Lee KY; Kim TS; Jung J; Shin JM
    Sci Rep; 2018 Jun; 8(1):8857. PubMed ID: 29891981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. kESVR: An Ensemble Model for Drug Response Prediction in Precision Medicine Using Cancer Cell Lines Gene Expression.
    Majumdar A; Liu Y; Lu Y; Wu S; Cheng L
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34070793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DeepTTA: a transformer-based model for predicting cancer drug response.
    Jiang L; Jiang C; Yu X; Fu R; Jin S; Liu X
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35348595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PANCDR: precise medicine prediction using an adversarial network for cancer drug response.
    Kim J; Park SH; Lee H
    Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38487849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Learning the cellular activity representation based on gene regulatory networks for prediction of tumor response to drugs.
    Xie X; Wang F; Wang G; Zhu W; Du X; Wang H
    Artif Intell Med; 2024 Jun; 152():102864. PubMed ID: 38640702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hi-GeoMVP: a hierarchical geometry-enhanced deep learning model for drug response prediction.
    Chen Y; Zhang L
    Bioinformatics; 2024 Mar; 40(4):. PubMed ID: 38614131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.